Benitec Biopharma Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 3940 TRUST WAY, HAYWARD, CA, 94545
Mailing Address 3940 TRUST WAY, HAYWARD, CA, 94545
Phone (510) 780-0819
Fiscal Year End 0630
EIN 000000000
Financial Overview
FY2025
$4.96M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-Q Quarterly financial report | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | January 30, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 26, 2026 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | December 8, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 3, 2025 | View on SEC |
| 4 Insider stock transaction report | December 3, 2025 | View on SEC |
Annual Reports
10-K September 22, 2025
- Early positive data for throat disease treatment
- New patents secured in Europe/Japan
Insider Trading
STRONG BUY 1 insiders
12 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.